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The contribution of smoking to regional mortality differences  
in the Netherlands 
Fanny Janssen1 ,2 
Alette Sigrid Spriensma3 ,4 
Abstract 
BACKGROUND 
Smoking is an important preventable determinant of morbidity and mortality. 
Knowledge about its role in regional mortality differences can help us to identify 
relevant policy areas, and to explain national mortality differences.  
 
OBJECTIVE 
We explored the extent to which the regional differences in all-cause mortality in the 
Netherlands could be due to smoking by examining its link with regional differences in 
smoking-attributable mortality.  
 
METHODS 
All-cause mortality, lung cancer mortality, and population numbers were obtained from 
Statistics Netherlands for the period 2004-2008, by 40 NUTS-3 regions, age, and sex. 
Smoking-attributable mortality was estimated using an adapted indirect Peto-Lopez 
method. We mapped regional differences in age-standardised all-cause mortality, 
smoking-attributable mortality fractions, and smoking- and non-smoking-related 
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mortality rates. We assessed spatial clustering, calculated correlations, and compared 
and decomposed regional variance. 
 
RESULTS 
Significant regional differences in all-cause mortality, exhibiting a random pattern, 
were found. Smoking-attributable mortality fractions, which ranged from 22% to 30% 
among males and 7% to 14% among females, correlated significantly with all-cause 
mortality, especially among males. Smoking-attributable mortality varied far more than 
all-cause mortality, while non-smoking-attributable mortality varied less than all-cause 
mortality. The variance in smoking-attributable mortality contributed 39% to the 
regional variance in all-cause mortality among males, and 30% among females.  
 
CONCLUSIONS 
Smoking-attributable mortality thus clearly contributed to the regional differences in 
all-cause mortality, especially among males. This finding can be linked to past regional 
differences in smoking behaviour and underlying regional differences in socio-
economic variables. 
 
 
 
1. Introduction 
It is well known that smoking is an important and preventable determinant of morbidity 
and mortality. Smoking contributes strongly to cancer of the lung, COPD, and cancer of 
the upper respiratory and digestive system; and to a lesser extent to coronary heart 
disease, stroke, and cancer of the bladder, stomach, kidney, and pancreas (U.S. 
Department of Health and Human Services 2004). Several studies have found large 
gaps in the life expectancies of smokers and non-smokers, amounting to between six 
and 10 years (Doll et al. 2004, Mamun et al. 2004, van Baal et al. 2006). Within 
Europe, smoking is the leading risk factor for premature mortality, and it has the 
greatest impact on the disease burden of all of the preventable lifestyle factors (World 
Health Organization 2002).  
The smoking epidemic has increased national mortality levels over a long period 
of time, firstly and more strongly for males than for females, with a time lag of about 30 
years between the increase plus subsequent decline in smoking prevalence, and the 
increase plus subsequent decline in smoking-attributable mortality (Lopez, Collishaw, 
and Piha 1994). Countries differ, however, in the timing of the onset of the epidemic, 
and in the pace at which they go through it. In Northern and Western Europe, the 
prevalence of smoking has been declining for several decades, especially for males. 
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Consequently, smoking-attributable mortality in these regions has been decreasing for 
males, whereas for females, the peak is approaching. In Eastern Europe, smoking-
attributable mortality among males is either peaking or just beginning to decline, 
whereas for females, it is still on the increase (Shafey, Dolwick, and Guindon 2003). 
Because of the important international differences in smoking and subsequent 
smoking-attributable mortality (e.g. Ezzati and Lopez 2004), many studies on the 
determinants of all-cause mortality differences between countries have looked into the 
role of smoking, and have found that smoking has had a significant impact (e.g., Bobak 
and Marmot 1996; Spijker 2003; Janssen, Kunst, and Mackenbach 2007; Staetsky 2009; 
Preston, Glei, and Wilmoth 2010a; Rostron and Wilmoth 2011).  
Less research has, however, been done on the determinants of regional or within-
country all-cause mortality differences in general, even though regional mortality 
differences exist (e.g., Shaw et al. 2000; Vallin, Meslé and Valkonen 2001; Bonneux, 
Huisman, and de Beer 2010; Office for National Statistics 2010). Moreover, gaining 
insight into the preventable determinants of smoking may not only allow us to identify 
relevant policy areas; it can also help us to explain national mortality differences 
(Vallin and Meslé 2004). The existing studies on regional or within-country mortality 
differences have mentioned a potential role of smoking (e.g., Papastergiou et al. 2008; 
Bonneux, Huisman, and de Beer 2010), for example in relation to socio-economic 
differences in mortality (e.g., Kunst, Looman, and Mackenbach 1990; Spijker 2004; 
Mackenbach, Kunst, and Looman 1991; Mackenbach, Looman, and Kunst 1989), but 
these studies did not examine the contribution of smoking to all-cause mortality. To 
assess the impact of tobacco on society, estimates of smoking-attributable mortality are 
regarded as very useful tools (e.g., Oliveira, Valente, and Leite 2008; Perez-Rios and 
Montes 2008). Based on the literature reviews on smoking-attributable mortality 
(Oliveira, Valente, and Leite 2008; Perez-Rios and Montes 2008) we can conclude that 
many studies have estimated smoking-attributable mortality, although national-level 
studies are much more common than regional studies, and different estimation methods 
have been used. When detailed and accurate data on smoking prevalence are lacking, 
the indirect Peto-Lopez method (Peto et al. 1992) is seen as a powerful alternative (see 
as well Pampel 2005), especially as it also circumvents the issue of the time lag 
between changes in smoking prevalence and change in mortality (Tanuseputro et al. 
2005). This method uses excess lung cancer mortality as a proxy for the cumulative 
exposure to smoking, which is then combined with relative risks of dying from smoking 
to estimate smoking-attributable mortality (Peto et al. 1992).  
Estimates of smoking-attributable mortality have only recently been used to 
actually explain differences in all-cause mortality (e.g., Janssen, Kunst, and 
Mackenbach 2007; Staetsky 2009; Preston, Glei, and Wilmoth 2010a; Rostron and 
Wilmoth 2011), even though they are powerful tools, which have been used to explain 
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sex differences in all-cause mortality trends (e.g., Pampel 2002). At the regional and 
within-country levels, studies linking geographical differences in smoking-attributable 
mortality to explanations of mortality differences are especially rare. The studies we 
came across focused on explaining regional differences in cause-specific mortality, but 
not at the within-country level (Ezzati et al. 2005a; Ezzati et al. 2005b). At the within-
country level, only very implicitly regional smoking-attributable mortality estimates 
have been compared with regional all-cause mortality (e.g., Tanuseputro et al. 2005).  
The above clearly demonstrates the need for studies on the role of smoking in 
regional all-cause mortality differences.  
Within the European Union, the Netherlands is among the countries that were the 
first to take up smoking, and that continue to have the highest percentage of daily 
smokers (World Health Organization 2010), although smoking prevalence is currently 
declining (STIVORO 2011). In particular, Dutch men born between 1897 and 1917 had 
a high level of lifetime exposure to smoking (Gunning-Schepers 1988), which is 
reflected in smoking prevalence rates among males of around 80% in the 1950s and 
1960s. Among Dutch women, the highest level of smoking prevalence, 42%, was 
reported in the surveys of 1967 and 1970 (STIVORO 2011). Smoking-attributable 
mortality among Dutch males reached its peak around 1983, and started to decline 
thereafter. Smoking-attributable mortality among Dutch females has not yet reached its 
peak. In 2005, among the total Dutch population, there were almost 20,000 smoking-
related deaths (Gelder, Hoogenveen, and Leent-Loenen 2010). In addition, about one-
eighth of the total disease burden in the Netherlands can be attributed to the use of 
tobacco (de Hollander et al. 2006).  
While earlier studies on regional mortality differences in the Netherlands 
mentioned the potential role of smoking (Kunst, Looman, and Mackenbach 1990; 
Kunst, Looman, and Mackenbach 1993; Mackenbach et al. 2004; Mackenbach, Kunst, 
and Looman 1991; Mackenbach, Looman, and Kunst 1989), none of these studies 
looked specifically at the role of smoking, or explicitly examined the Dutch regional 
variations in smoking-attributable mortality.  
The objective of this paper is, therefore, to explore the extent to which the regional 
differences in all-cause mortality in the Netherlands could be due to smoking by 
examining the link between regional differences in all-cause mortality and regional 
differences in smoking-attributable mortality.  
Our paper is intended to both advance the study of regional all-cause mortality 
differences, and to improve our understanding of the significance of smoking-
attributable mortality.  
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2. Data and methods 
To study our objective, aggregated deaths by all-cause and lung cancer (ICD10: C33-
34) over the period 2004-2008, by age (0-39, 40-44, …, 85-89, 90+), sex, and region 
(40 NUTS-3 level regions (the so-called COROP regions)) were obtained from the 
Cause of Death Statistics (Doodsoorzakenstatistiek) from Statistics Netherlands. The 
associated population numbers were obtained by five-year age groups. 
To estimate smoking-attributable mortality by region, age, and sex, we used a 
more detailed but simplified application of the indirect Peto-Lopez method (Peto et al. 
1992), which is based on relative risks for all-cause mortality instead of for specific 
causes of death, and data by five-year age groups (Mackenbach et al. 2004). In the first 
step, historical smoking exposure (p) was estimated by comparing the observed regional 
age- and sex-specific lung cancer mortality rates with the age- and sex-specific 
smoothed lung cancer rates of smokers and never-smokers of the ACS CPS-II study by 
five-year age groups (Peto et al. 1992). In the second step, the regional age- and sex-
specific smoking-attributable mortality fractions—i.e., the proportion of all deaths 
attributable to smoking—was estimated as a function of the proportion of the 
population who are exposed to smoking (p) and the relative risk of smoking (RR), using 
the standard epidemiological formula for a so-called etiological fraction EF = p(RR-
1)/(p(RR-1)+1). The age- and sex-specific relative risks were obtained by dividing the 
all-cause mortality rates among CPS-II smokers by the all-cause mortality rates among 
CPS-II non-smokers. In addition, a second level polynomial was fitted (Bonneux, 
Looman, and Coebergh 2003). To take into account residual confounding and to obtain 
conservative estimates of smoking-attributable mortality, the sex- and age-specific 
relative risks were adjusted downwards by reducing the excess risk by 30%, as was 
proposed by Ezzati and Lopez (2003). Smoking-attributable mortality rates were 
obtained by multiplying all-cause mortality rates with the obtained smoking-attributable 
mortality fractions. Non-smoking-attributable mortality rates were subsequently 
obtained by subtracting smoking-attributable mortality rates from all-cause mortality 
rates. 
In analysing the data, we combined demographic and geographical techniques. 
Directly age-standardised crude death rates (ASCDR) were calculated for all-cause 
mortality, smoking-attributable mortality, and non-smoking-attributable mortality, by 
sex and region. The Dutch population by age and sex in 2004-2008 was used as a 
standard. Age-standardised smoking-attributable mortality fractions were calculated by 
dividing the ASCDR for smoking-attributable mortality with the ASCDR for all-cause 
mortality, again by sex and region.  
We graphically presented the regional differences in age-standardised all-cause 
mortality rates, smoking-attributable mortality fractions, smoking-attributable mortality 
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rates, and non-smoking-attributable mortality rates, by sex, using ArcGIS. We classified 
our data according to five equally large intervals. The significance level of the 
difference in the age-standardised rates and in the smoking-attributable fractions 
between a specific NUTS-3 region and the Netherlands as a whole was assessed using 
the formula for the Z-score of the difference between proportions, assuming a normal 
distribution.  
To determine whether regions with high (cause-specific) mortality rates were 
clustered together or were randomly distributed, spatial autocorrelation was assessed 
using global Moran’s I in ArcGIS. The global Moran’s I takes into account the 
difference between the region-specific ASCDR and the average for all regions 
combined. The values of the Moran’s I generally can run from minus one to one. Zero 
means the pattern is totally random, minus one indicates the values are distributed 
dispersedly, and one indicates a complete clustering of the values. (Mitchell 2005; 
Gatrell 2002) 
To compare the regional variance between all-cause mortality, smoking-
attributable mortality, and non-smoking-attributable mortality, we calculated the 
variance based on the comparative mortality figures (CMF). CMFs are the directly 
standardised mortality rates in a region, divided by the average mortality rate.  
To assess the contribution of regional variance in smoking-attributable mortality to 
the regional variance in all-cause mortality, we decomposed the regional variance in all-
cause mortality into the variance in smoking-attributable mortality, the variance in non-
smoking-attributable mortality, and two times the covariance between smoking-
attributable and non-smoking-attributable mortality. We used the age-standardised 
death rates for this purpose. 
 
 
3. Results 
All-cause mortality in the Netherlands in the period 2004-2008 amounted to 81.0 deaths 
per 10,000 population for males and 84.4 for females. The age-standardised all-cause 
mortality rate (ASCDR) for males ranged from 89.6 (eastern Groningen) to 72.8 (Delft 
and Westland), and for females from 90.4 (southern Limburg) to 75.6 (remaining 
Zeeland), again expressed in deaths per 10,000 population (see Figure 1). In general, 
eastern Groningen and southern Limburg (peripheral regions in the east) showed the 
highest mortality, whereas regions in the middle of the Netherlands (around Utrecht), 
Zeeland (south-west), and parts of Drenthe show the lowest ASCDR. In many regions, 
the ASCDR differs significantly from the Dutch average. For both males and females, 
12 out of 40 regions had significantly higher ASCDR than average, and 15 regions had 
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significantly lower ASCDR than average. According to the Moran’s I (see Table 1), a 
random non-significant pattern existed for ASCDR among both males and females. 
We estimated for the Netherlands as a whole that 26.6% of all-cause mortality was 
attributable to smoking among men, compared to just 11.0% among women. Age-
standardised smoking-attributable mortality fractions ranged from 22.4% to 30.3% 
among males, with higher levels found in the eastern regions, especially in northern 
Limburg and in western and mid Noord-Brabant (see Figure 2). Lower levels were 
observed in the west, especially in regions surrounding the agglomeration of Haarlem. 
Among women, age-standardised smoking-attributable mortality fractions ranged from 
6.8% to 14.4%, with low levels observed in Friesland, western Drenthe, north-western 
Overijssel, and Zeeland. The clustering that was observed for smoking-attributable 
mortality fractions proved significant among both males and females (Table 1).  
 
Figure 1: Regional differences in age-standardised all-cause mortality rates 
(per 10,000), by sex, the Netherlands, by NUTS-3 region, 2004-2008 
 
 
Source data and shape-file: Statistics Netherlands. Own calculations. 
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Table 1: Spatial clustering by cause of death and sex, the Netherlands, across 
40 NUTS-3 regions, 2004-2008 
 Males Females 
 Moran’s I * p-value Moran’s I p-value 
Age-standardised all-cause mortality rate 0.14 0.1661 -0.06 0.7577 
Age-standardised smoking-attributable 
mortality fraction 
0.31 0.0059 0.29 0.0109 
Age-standardised smoking-attributable 
mortality rate 
0.29 0.0102 0.19 0.0827 
Age-standardised non-smoking-
attributable mortality rate 
-0.09 0.5820 0.16 0.1260 
 
Notes: * a measure of spatial autocorrelation, which ranges from -1 to 1, where 0 indicates a totally random pattern, -1 indicates 
dispersedly distributed values, and 1 indicates complete clustering 
 
 
Figure 2: Regional differences in age-standardised smoking-attributable 
mortality fractions (%), by sex, the Netherlands, by NUTS-3 region, 
2004-2008 
 
 
Source data and shape-file: Statistics Netherlands. Own calculations. 
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A clear correlation between age-standardised smoking-attributable mortality 
fractions and age-standardised all-cause mortality rates (ASCDR) across the 40 NUTS-
3 regions were found to exist among males (Pearson correlation coefficient r = 0.78, p = 
0.000). For females, the correlation was less strong (r = 0.49, p = 0.001) (see Figure 3). 
For both males and females, remaining Zeeland (32) and northern Drenthe (7) both had 
low smoking-attributable mortality fractions and low ASCDR, whereas eastern 
Groningen (1) and southern Limburg (39) both had high smoking-attributable mortality 
fractions and high ASCDR. Among women, two interesting “deviating” groups could 
be identified: group A consists of regions with low smoking-attributable mortality 
fractions and average ASCDR (Friesland, western Overijssel), while group B consists 
of mostly urban areas with the highest shares of smoking-attributable mortality, but 
without the highest ASCDR.  
 
Figure 3: Age-standardised smoking-attributable mortality fractions (%) 
plotted against age-standardised all-cause mortality rates (per 
10,000), across 40 NUTS-3 regions, by sex, the Netherlands, 2004-
2008 
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Figure 3: (Continued) 
 
 
Notes: Males: r = 0.78, p = 0.000, Females: r = 0.49; p = 0.001 
Source data: Statistics Netherlands. Own calculations. 
 
 
For the Netherlands as a whole, the smoking-attributable mortality rate amounted 
to 21.5 and 9.3 deaths per 10,000 for males and females, respectively. For males, the 
age-standardised smoking-attributable mortality rate (ASCDRSM) ranged from 17.1 to 
26.2 deaths per 10,000, and the regions that experienced the lowest and highest 
smoking-attributable mortality were the same as those that experienced the lowest and 
highest all-cause mortality (see Figure 4). For females, the ASCDRSM ranged from 5.1 
to 12.3 deaths per 10,000, and showed a quite different pattern from that of all-cause 
mortality, with various regions in the west having higher ASCDRSM than the 
Netherlands as a whole. The ASCDRSM showed slight clustering among males, but no 
significant clustering among females (Table 1). 
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Figure 4: Regional differences in age-standardised smoking-attributable 
mortality rates (per 10,000), by sex, the Netherlands, by NUTS-3 
region, 2004-2008 
 
 
Source data and shape-file: Statistics Netherlands. Own calculations. 
 
 
When we compared the regional differences between non-smoking-attributable 
mortality (ASCDRNS) and all-cause mortality (ASCDR), we found that the same 
regions showed the lowest and the highest levels for both males and females (see Figure 
1 and Figure 5). For ASCDRNS, fewer regions showed a significant difference from the 
average than for ASCDR, especially among males.  
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Figure 5: Regional differences in age-standardised non-smoking-attributable 
mortality rates (per 10,000), by sex, the Netherlands, by NUTS-3 
region, 2004-2008 
 
Source data and shape-file: Statistics Netherlands. Own calculations. 
 
 
A comparison of the variance in the comparative mortality figure (CMF) and an 
additional F-test revealed statistically significantly larger regional differences for 
smoking-attributable mortality than for all-cause mortality (p=0.000). Women exhibited 
statistically significantly higher variance in smoking-attributable mortality (p=0.001) 
than men. For non-smoking-attributable mortality, the variance was statistically 
significantly lower than for all-cause mortality for males (p=0.015), and was also lower, 
but not statistically significant, for females (p=0.453). (Table 2)  
After decomposing the variance in all-cause mortality into the variance in 
smoking- and non-smoking-attributable mortality using the age-standardised rates, we 
found that the variance in smoking-attributed mortality contributed 39% for males and 
30% for females. (Table 3) 
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Table 2: The variance of the comparative mortality figures (CMF) and 
associated F-tests, by cause of death and sex, the Netherlands, across 
40 NUTS-3 regions, 2004-2008 
 Males Females 
Variance    
All-cause mortality rate (CMF) 23.34 16.14 
Smoking-attributable mortality rate (CMF) 128.31 399.34 
Non-smoking-attributable mortality rate (CMF) 10.55 12.67 
   
p values F-test difference in variance   
Smoking-attributable mortality vs. all-cause mortality 0.000 0.000 
Non-smoking-attributable mortality vs. all-cause mortality 0.015 0.453 
 
 
Table 3: Comparison of the variance in age-standardised rates by cause of 
death and decomposition of the variance in all-cause mortality rates, 
by sex, the Netherlands, across 40 NUTS-3 regions, 2004-2008 
 Males Females 
Variance all-cause mortality (ASCDR) 15.32 11.49 
Variance smoking-attributable mortality (ASCDR) 5.94 3.47 
Variance non-smoking-attributable mortality (ASCDR) 3.74 7.14 
Covariance smoking- and non-smoking-attributable mortality rates 
(ASCDRs) 
2.82 0.48 
Variance smoking-attributable mortality divided by variance all-
cause mortality (ASCDRs) 
0.39 0.30 
 
 
4. Conclusion and discussion 
4.1 Summary of our findings 
For the Netherlands, significant regional differences in age-standardised all-cause 
mortality rates, exhibiting a random pattern, were found to exist. For males, age-
standardised smoking-attributable mortality fractions ranged from 22% to 30%, with 
higher levels found in the east and the mid-south. For females, the corresponding 
fractions were 7% to 14%, with low levels found in the mid-north and Zeeland. The 
age-standardised smoking-attributable mortality fractions correlated significantly with 
age-standardised all-cause mortality rates across 40 NUTS-3 regions, especially for 
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males. Smoking-attributable mortality varied much more than all-cause mortality. 
Regional variance in CMF was smaller for non-smoking-attributable mortality than for 
all-cause mortality, although for females this was not statistically significant. The 
variance (age-standardised rates) in smoking-attributable mortality contributed 39% to 
the regional variance in all-cause mortality among males, and 30% among females. 
 
 
4.2 A comparison of our findings to earlier results 
As was noted in the introduction, there are very few studies linking smoking-
attributable mortality to all-cause mortality differences within a single country. 
Tanuseputro et al. (2005) mentioned the increasing smoking-attributable mortality from 
west to east in Canada in 2000-2001, as well as the presence of a west-to-east gradient 
for life expectancy, but did not discuss these observations in any detail. In addition, the 
studies on within-country differences in smoking-attributable mortality often briefly 
describe the regional differences (e.g., Illing and Kaiserman 1995, 1999, 2004) without 
relating them to all-cause mortality differences. Within Europe, a paper about smoking-
attributable mortality in Germany was recently published (Mons 2011). For the 16 
German federal states, smoking-attributable mortality fractions were found to range 
from 18% to 23% among males, and from 4% to 10% among females. These levels are 
lower than those of the Netherlands, but the ranges are comparable, especially for 
females. It should be noted that any comparison of findings on regional variation is 
likely to be affected by the number of regions being compared and the degree of 
heterogeneity in the selected regions. 
To our knowledge, only one recent study has quantified the role of smoking in 
within-country differences in all-cause mortality within Europe. Jenum, Stensvold, and 
Thelle (2001) observed for 25 districts in Oslo that the differences in the proportion of 
daily smokers aged 40 in 1985-1988 explained 70% of the differences in all-cause 
mortality among males aged 45-74 in 1991-1995, and 46% of the differences among 
females. Their finding of a higher contribution of smoking than we did in our research 
is likely because they used more restricted age groups.  
 
 
4.3 Can the regional differences in smoking-attributable mortality be fully 
assigned to smoking? 
To estimate smoking-attributable mortality, we used a more detailed but simplified 
application of the indirect Peto-Lopez method. Our estimates for the Netherlands as a 
whole for 2000 were approximately the same as the estimates from the Peto-Lopez 
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method and from a recently introduced regression method by Preston, Glei, and 
Wilmoth (Preston, Glei, and Wilmoth 2010b), which showed its validity. Our estimates 
were, however, slightly higher for males than the estimates from Rostron’s modified 
version of the Preston et al. method, and from his modified version of the Peto-Lopez 
method (Rostron 2010). It is important to note, however, that any possible bias in, for 
example, the relative risks or the amount of adjustment being chosen will affect the 
different regions in the same manner, and thus will not affect the extent of the regional 
differences in smoking-attributable mortality. 
What could have affected regional variations in smoking-attributable mortality is, 
however, the application of the same ratio between background lung cancer mortality 
(lung cancer mortality not due to smoking) and smoking-attributable lung cancer 
mortality for each region.  
Lung cancer mortality might indeed stem not only from smoking, but also from 
environmental factors, like air contamination and passive smoking (Epstein 1974; 
Tyczynski, Bray, and Parkin 2003; Engholm, Palmgren, and Lynge 1996), as well as 
from exposure to certain occupational agents (e.g., arsenic, asbestos, chromium, nickel, 
and vinyl chloride) at shipyards, building insulation material building sites, 
metallurgical industry sites, and painting business sites (Williams and Sandler 2001). 
The relative role of smoking versus background mortality might therefore be different 
for different regions. 
For the Netherlands, Kunst, Looman, and Mackenbach (1993) observed that 
regional differences in lung cancer mortality for the population aged 45-85+ in the 
Netherlands in 1980-84 showed clear associations with past smoking behaviour (for 
females smoking in 1972, for males 65+ smoking in 1930), some associations with past 
work in the transport and manufacturing industries (1971) (males aged 45-64 only), and 
strong associations with air contamination in 1979-80.  
It should be noted, however, that the strong associations with air contamination 
were not regarded as solid evidence of an effect. More importantly, our observation of 
quite different patterns between the sexes in current smoking-attributable mortality—
which are in line with the patterns for lung cancer mortality—suggest that the role of 
environmental factors may be small. 
A potential effect of regional differences in exposure to occupational agents 
cannot, however, be disregarded completely, as this exposure is likely to affect men and 
women differently (Kunst, Looman, and Mackenbach 1993). Data to support this 
assumption are, however, not readily available for the Netherlands. It should be noted 
that Kunst, Looman, and Mackenbach (1993) only observed an association for males 
aged 45-64. More importantly, the effect of exposure to occupational agents on lung 
cancer and, subsequently, on smoking-attributable mortality is very limited relative to 
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the role of smoking (Epstein 1974; Tyczynski, Bray, and Parkin 2003; Engholm, 
Palmgren, and Lynge 1996). 
Instead, the observed clear regional patterns in smoking-attributable mortality in 
the Netherlands can be closely linked to the available—albeit scarce—data on regional 
differences in past smoking behaviour, taking into account a lag time of about 30-40 
years (Lopez, Collishaw, and Piha 1994). Among women, data on smoking for 1972 
and 1975 by province (NUTS-2) and sex for people aged 65 and over (van Reek 1979) 
showed consistently low levels of smoking in Friesland (4% and 5%) and Drenthe 
(6%), and also in Zeeland for 1975 (5%). The observed high levels of smoking among 
females in Noord-Holland (20% and 16%) and Zuid-Holland (16% and 13%) were also 
in line with our results. For males, data on both ages 55-64 (1972) and ages 65 and over 
(1972, 1975) are available, and showed consistently high percentages of smokers in 
Limburg: 82%, 74%, and 73%, respectively. 
The observed regional differences in smoking-attributable mortality therefore seem 
to be primarily related to differences in past exposure to smoking, not to environmental 
factors, and potentially—though to a small extent—to regional differences in certain 
types of industries.  
 
 
4.4 What factors explain the regional differences in past smoking and subsequent 
smoking-attributable mortality? 
Among the factors that can contribute to the regional differences in both past smoking 
and subsequent smoking-attributable mortality are the regional differences in past 
socio-economic status (SES). We have observed high levels of smoking-attributable 
mortality in the province of Groningen, in southern Limburg, and in other regions in the 
east, which are traditionally less wealthy areas (Verkade, Vermeulen, and Brouwer 
2006). However, not all of the regions that have traditionally had lower SES, including 
the peripheral regions, and especially the northern provinces (Verkade, Vermeulen, and 
Brouwer 2006), showed elevated smoking-attributable mortality, and not all of the 
traditionally richer regions showed lower smoking-attributable mortality. Thus, other 
factors seem to play a role as well.  
Regional differences in urbanicity are likely contributors, since urban areas tend to 
have higher lung cancer mortality and higher smoking prevalence than rural areas (e.g., 
Kunst, Looman, and Mackenbach 1993; Völzke et al. 2006; Zwakhals,  Giesbers, and 
Deuning 2010). The higher smoking-attributable mortality among Dutch women that 
was observed in some of the regions in the west might be due to the consistently higher 
urbanicity levels in the Randstad, the urban agglomeration in the west of the 
Netherlands. However, other regions in the more rural north and east also exhibited 
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high smoking-attributable mortality among women. Among men, smoking-attributable 
mortality was especially high in the more rural south, east, and northeast of the 
Netherlands.  
Another potential factor could be religion. For the Netherlands, Mackenbach, 
Kunst, and Looman (1991) assigned the high standardised all-cause mortality ratios in 
the south of the Netherlands over the period 1980-1984 by the higher smoking 
prevalence in the 1970s among Roman Catholics, who live predominantly in these 
regions. These past differences in smoking prevalence might nowadays affect 
differences in smoking-attributable mortality. The higher smoking-attributable mortality 
in some regions in the south, which was only clearly observed for males, could indeed 
be due to religion. 
In sum, regional differences in socio-economic status seem to be the most 
important—but not the only—factor that explains the regional differences in smoking 
and subsequent smoking-attributable mortality.  
 
 
4.5 Sex differences in the contribution of smoking and in regional patterns of 
smoking-attributable mortality 
Our results showed that smoking-attributable mortality, and thus past smoking 
behaviour, contributed to the regional differences in all-cause mortality, although these 
effects were especially clear among males, and were less clear among females. This 
difference between the sexes was also observed by Jenum, Stensvold, and Thelle 
(2001), and can, in our view, be linked to the differences between men and women in 
their experiences of the smoking epidemic (Lopez, Collishaw, and Piha 1994). In north-
western Europe, men generally took up smoking first, with women following one or 
two decades later. By the time women took up smoking, more information was 
available about the negative effects of smoking, which led to a lower maximum 
smoking prevalence among females than among males. (Lopez, Collishaw, and Piha 
1994) Data for the Netherlands in 1970 illustrate this striking sex difference: 42% of 
women smoked, compared to 75% of men (STIVORO 2011). Thus, smoking has been 
less widespread among women than among men, which leaves for women more room 
for contributions by other determinants in regional mortality differences.  
Two likely explanations for the observed sex difference in the regional patterns in 
smoking-attributable mortality are (i) sex differences in the timing of the diffusion of 
the smoking epidemic from high-income regions to low-income regions, and (ii) sex 
differences in the association between urbanicity and smoking.  
The first explanation can be related to the general observed trend in social 
gradients in chronic disease risk factors (Fleischer 2010): that is, people with higher 
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socio-economic status (SES) tend to adopt new lifestyles first, while people with lower 
SES tend to take up these lifestyles later, but then generally have more difficulty 
quitting (e.g., Fleischer 2010). This trend has indeed been observed for smoking (e.g., 
Kunst, Looman, and Mackenbach 1993). Because of the different timing between the 
sexes in the uptake of smoking, this diffusion is likely to have occurred first among 
males and later among females. Data for the Netherlands confirm this assumption. For 
the Netherlands in the 1960s, higher smoking prevalence was observed among males 
with lower SES than those with higher SES (aged 20+: 86%-87% vs. 70%-73%) and 
among females with higher SES than those with lower SES (aged 20-34: 60% vs. 51%; 
35-49: 56% vs. 46%; and 50+: 30% vs. 18%) (van Reek 1982). In the 1970s, however, 
higher smoking prevalence was observed among both Dutch males and females (aged 
20-49) with lower SES than among those with higher SES (males: aged 20+: 59%-67% 
vs. 54%-59%; females: aged 20-49: 53%-56% vs. 38%-41%) (van Reek 1982).  
In considering the second explanation, it is important to note that, in recent years, 
the association between urbanicity, smoking, and lung cancer mortality seems to have 
become less pronounced for males (Schouten et al. 1996; Fleischer 2010). Also, in our 
study we found less evidence for a role of urbanicity among males than among females. 
This is in line with the increase in smoking prevalence among Dutch females in the 
1970s, which still occurred predominantly in the urban population (Schouten et al. 
1996, van Reek 1983). It is also likely that a diffusion process is taking place from 
urban to rural areas, which has already started for males, but is still less widespread 
among females. 
 
 
4.6 Explaining the remaining regional variation in all-cause mortality 
When smoking-attributable mortality is excluded from all-cause mortality, regional 
differences in mortality still exist. For males, the regions with remaining significant 
higher or lower than average non-smoking-attributable mortality are also predominantly 
the regions showing significantly higher or lower than average smoking-attributable 
mortality. This could indicate that, among males, smoking is associated with other 
lifestyle-related factors (e.g., excessive alcohol consumption or limited physical 
exercise) that could, together with other potential factors, contribute to regional 
differences in mortality in the Netherlands. For females, we see a slightly different 
pattern. Many of the regions that are shown to have significantly higher mortality when 
smoking-attributable mortality is excluded do not have significantly higher smoking-
attributable mortality. This indicates that, for women, factors that are not related to 
smoking also contribute to regional differences in all-cause mortality (e.g., medical 
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care, environment). In sum, factors in addition to smoking seem to have contributed to 
regional differences in all-cause mortality in the Netherlands. 
 
 
4.7 Overall conclusion and implications 
Our finding that smoking-attributable mortality is an important contributor to all-cause 
mortality—which can in turn be linked to past regional differences in smoking 
behaviour, mainly as a result of past regional differences in socio-economic variables—
indicates that smoking behaviour can leave its mark on (regional differences in) 
mortality long before the associated mortality sets in.  
Although they have been experiencing a decline in smoking prevalence in recent 
decades, the effects of smoking on mortality for the countries in the last phase of the 
smoking epidemic will remain for some time to come, based on current levels of 
smoking prevalence. For females, the role of smoking is expected to further expand due 
to on-going increases in smoking-attributable mortality in the coming years.  
Regional differences in smoking-attributable mortality might become smaller as 
women, like men, reach the final stage of the smoking epidemic, and the differences in 
smoking prevalence between the sexes diminish. Accordingly, the diffusion of smoking 
behaviour from high- to low-income regions—and, potentially, from urban to rural 
areas—is likely to fade, as has already been observed for males.   
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Appendix  
Figure A: Map with the 40 NUTS-3 (=COROP) regions in the Netherlands 
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1. Eastern Groningen  11. South-western 
Overijssel  
21. Agglomeration 
Haarlem  
31. Zeeuwsch-
Vlaanderen  
2. Delfzijl and 
surroundings  
12. Twente  22. Zaanstreek  32. Remaining Zeeland  
3. Remaining 
Groningen  
13. Veluwe  23. Great Amsterdam 33. Western Noord-
Brabant  
4. Northern Friesland  14. Achterhoek  24. The Gooi and 
Vechtstreek  
34. Mid Noord-Brabant  
5. South-western 
Friesland  
15. Arnhem and 
Nijmegen  
25. Agglomeration 
Leiden and 
Bollenstreek  
35. North-eastern 
Noord-Brabant  
6. South-eastern 
Friesland  
16. South-western 
Gelderland  
26. Agglomeration 
The Hague  
36. South-eastern 
Noord-Brabant  
7. Northern Drenthe  17. Utrecht  27. Delft and 
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37. Northern Limburg  
8. South-eastern 
Drenthe  
18. Upper north Noord-
Holland  
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19. Alkmaar and 
surroundings  
29. Great Rijnmond  39. Southern Limburg  
10. Northern Overijssel  20. IJmond  30. South-eastern 
Zuid-Holland  
40. Flevoland  
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